STOCK TITAN

Accenture Plc Ireland SEC Filings

ACN NYSE

Welcome to our dedicated page for Accenture Plc Ireland SEC filings (Ticker: ACN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Accenture plc filings document the regulatory record of a global professional services company, including operating results, material events, governance matters and capital-structure disclosures. The company’s 8-K reports cover quarterly and annual financial results, non-GAAP measures such as free cash flow and local-currency revenue and bookings, and material financing arrangements including senior unsecured revolving credit facilities used for general corporate purposes and to support its commercial paper program.

Proxy materials describe shareholder voting matters, board and executive compensation disclosures, equity award information and governance practices. Other filings record leadership and organizational changes, including Accenture’s integrated Reinvention Services business unit, as well as risk, liquidity and financial reporting topics relevant to its consulting, technology and operations services model.

Rhea-AI Summary

Accenture insider plans a small share sale under Rule 144. A person named John F. Walsh has filed to sell 14 Class A Ordinary shares of Accenture through UBS Financial Services on the NYSE, with an approximate sale date of February 4, 2026. These shares were acquired as a stock award from the issuer on February 1, 2026. The filing also shows that Walsh sold 3,986 Class A Ordinary shares in a prior transaction on January 27, 2026, generating gross proceeds of $1,101,644.30.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Accenture plc executive Manish Sharma reported a disposition of 1,928 Class A ordinary shares. The transaction occurred on February 1, 2026 at a reported price of $262.22 per share under transaction code F. Following this event, Sharma beneficially owns 5,129 Class A shares directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Accenture plc Chair and CEO Julie Spellman Sweet, who also serves as a director, reported a disposition of 10,696 Class A ordinary shares on February 1, 2026 at a price of $262.22 per share. Following this transaction, she directly beneficially owned 26,650 Class A ordinary shares of Accenture.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Accenture plc executive Melissa A. Burgum reported a small share disposition. As Chief Accounting Officer, she reported the disposition of 131 Class A ordinary shares on February 1, 2026 at a price of $262.22 per share. Following this transaction, she directly beneficially owned 8,048 Class A ordinary shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Accenture plc Chief Financial Officer trades company stock

Accenture plc Chief Financial Officer Angie Y. Park reported a disposition of 602 Class A ordinary shares on February 1, 2026 at a price of $262.22 per share. After this transaction, Park beneficially owned 12,378 Class A ordinary shares directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Accenture plc CEO-The Americas John F. Walsh reported a disposition of Class A ordinary shares. On February 1, 2026, a transaction coded “F” involved 2,235 Class A ordinary shares at $262.22 per share. After this transaction, he directly beneficially owned 24,986 Class A ordinary shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Accenture plc executive Mauro Macchi, Chief Executive Officer-EMEA, reported a disposition of Class A ordinary shares. On 02/01/2026, he disposed of 1,755 shares at $262.22 per share, a transaction coded “F.” Following this, he directly beneficially owns 5,368 Class A ordinary shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

A person associated with the issuer has filed a notice of intent to sell 302 Class A Ordinary shares through UBS Financial Services on the NYSE, with an aggregate market value of $75,500.00. The filing notes that 660,432,542 shares of this class were outstanding at the time of the notice, which is a baseline figure, not the amount being sold.

The 302 shares to be sold were received as a stock award from the issuer on 02/01/2026. The form also reports that during the prior three months, the same seller disposed of 3,588 Class A Ordinary shares on 01/26/2026 for gross proceeds of $1,008,280.54. The seller represents that they are not aware of any undisclosed material adverse information about the issuer’s operations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

ACN insider Manish Sharma filed a notice of proposed sale under Rule 144 for up to 3,450 Class A Ordinary shares through UBS Financial Services on the NYSE, with an aggregate market value of 860,568.00. The shares come from a stock award dated 02/01/2026.

During the prior three months, Sharma also sold 2,731 Class A Ordinary shares on 01/14/2026 for gross proceeds of 786,870.47. The filing includes a representation that the seller is not aware of undisclosed material adverse information about the issuer.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

Accenture’s Class A ordinary shares are being prepared for sale under Rule 144 by Julie Sweet. The notice covers 5,500 Class A ordinary shares, to be sold through UBS Financial Services Inc. on the NYSE, with an aggregate market value listed as 1,371,920.00. These shares were acquired as a stock award from the issuer on 02/01/2026.

The filing also discloses prior sales by Julie Sweet over the past three months: 5,917 Class A ordinary shares sold on 11/05/2025 for gross proceeds of 1,459,276.57, and 1,694 shares sold on 01/14/2026 for 488,380.20. Shares outstanding are reported as 660,432,542 Class A ordinary shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other

FAQ

How many Accenture Plc Ireland (ACN) SEC filings are available on StockTitan?

StockTitan tracks 282 SEC filings for Accenture Plc Ireland (ACN), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Accenture Plc Ireland (ACN)?

The most recent SEC filing for Accenture Plc Ireland (ACN) was filed on February 4, 2026.